US Stock MarketDetailed Quotes

Stoke Therapeutics (STOK)

Watchlist
  • 35.340
  • -0.200-0.56%
Close Apr 16 16:00 ET
  • 35.600
  • +0.260+0.74%
Post 19:19 ET
2.09BMarket Cap-294.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Stoke Therapeutics (STOK) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
152.49%45.59M
-31.31%-30.45M
-40.49%-30.37M
-45.46%-25.42M
636.62%131.83M
-7.13%-86.85M
-12.33%-23.19M
-25.21%-21.62M
19.83%-17.48M
-15.03%-24.57M
Net income from continuing operations
92.26%-6.89M
-452.70%-57.93M
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
-16.98%-26.37M
Operating gains losses
--145K
--153K
----
----
----
----
----
----
----
----
Depreciation and amortization
-18.70%1.77M
-23.00%405K
-18.15%442K
-18.61%446K
-15.28%477K
-11.83%2.18M
-15.71%526K
-15.23%540K
-10.31%548K
-5.70%563K
Other non cash items
6.31%2.41M
11.68%650K
-4.20%547K
8.90%612K
8.91%599K
0.22%2.27M
-1.36%582K
1.24%571K
1.08%562K
0.00%550K
Change In working capital
158.09%16.35M
184.13%16.98M
65.49%-1.12M
-36,976.67%-11.12M
347.56%11.61M
-366.67%-28.14M
-2,205.83%-20.18M
-823.93%-3.24M
-102.80%-30K
20.18%-4.69M
-Change in receivables
-8,436.00%-4.27M
1,011.41%3.31M
----
----
----
---50K
--298K
----
----
----
-Change in prepaid assets
69.48%-545K
112.64%220K
494.94%5.64M
-497.83%-3.85M
-632.09%-2.56M
-437.62%-1.79M
-228.68%-1.74M
284.44%948K
-136.22%-644K
83.29%-349K
-Change in payables and accrued expense
589.41%21.29M
308.54%8.9M
751.67%4.88M
-22.70%2.77M
347.06%4.74M
196.26%3.09M
289.64%2.18M
-137.13%-749K
180.80%3.58M
-646.72%-1.92M
-Change in other working capital
99.56%-130K
121.71%4.54M
-31.22%-4.06M
-238.78%-10.04M
489.06%9.43M
-777.11%-29.39M
-1,838.09%-20.91M
-66.88%-3.09M
-179.61%-2.96M
41.47%-2.42M
Cash from discontinued investing activities
Operating cash flow
152.49%45.59M
-31.31%-30.45M
-40.49%-30.37M
-45.46%-25.42M
636.62%131.83M
-7.13%-86.85M
-12.32%-23.19M
-25.22%-21.62M
19.83%-17.48M
-15.03%-24.57M
Investing cash flow
Cash flow from continuing investing activities
-73.82%-186.81M
-7,555.56%-61.06M
130.31%9.09M
-68.19%-148.48M
36.48%13.63M
-201.44%-107.48M
-94.46%819K
-305.27%-30M
-476.08%-88.28M
-81.18%9.99M
Net PPE purchase and sale
-230.05%-670K
-452.38%-232K
-28.16%-132K
-234.78%-154K
-1,166.67%-152K
87.44%-203K
81.66%-42K
73.11%-103K
94.52%-46K
92.73%-12K
Net investment purchase and sale
-73.52%-186.14M
-7,164.92%-60.83M
130.86%9.23M
-68.11%-148.32M
37.84%13.78M
-199.73%-107.27M
-94.26%861K
-299.34%-29.9M
-462.92%-88.23M
-81.22%10M
Cash from discontinued investing activities
Investing cash flow
-73.82%-186.81M
-7,555.56%-61.06M
130.31%9.09M
-68.19%-148.48M
36.48%13.63M
-201.44%-107.48M
-94.46%819K
-305.27%-30M
-476.08%-88.28M
-81.18%9.99M
Financing cash flow
Cash flow from continuing financing activities
-25.71%97.39M
16,157.22%92.34M
-61.76%3.12M
-99.54%554K
-19.98%1.37M
147.31%131.09M
-92.26%568K
1,351.78%8.16M
251,254.17%120.65M
-96.19%1.72M
Net common stock issuance
-31.87%87.78M
8,778,300.00%87.78M
--0
--0
--0
147.38%128.84M
-99.99%1K
--7.66M
--119.88M
-97.10%1.3M
Proceeds from stock option exercised by employees
326.13%9.61M
703.70%4.56M
520.28%3.12M
-27.68%554K
228.71%1.37M
143.41%2.25M
11,240.00%567K
-10.50%503K
1,495.83%766K
34.41%418K
Cash from discontinued financing activities
Financing cash flow
-25.71%97.39M
16,157.22%92.34M
-61.76%3.12M
-99.54%554K
-19.98%1.37M
147.31%131.09M
-92.26%568K
1,351.78%8.16M
251,254.17%120.65M
-96.19%1.72M
Net cash flow
Beginning cash position
-32.93%128.78M
-44.14%84.12M
-47.30%102.27M
53.84%275.61M
-32.93%128.78M
68.25%192.01M
-20.97%150.59M
0.74%194.05M
-6.16%179.15M
68.25%192.01M
Current changes in cash
30.67%-43.84M
103.79%826K
58.23%-18.15M
-1,263.78%-173.35M
1,241.69%146.83M
-181.19%-63.23M
-1,588.46%-21.81M
-1,986.41%-43.46M
765.49%14.9M
-116.75%-12.86M
End cash Position
-34.04%84.94M
-34.04%84.94M
-44.14%84.12M
-47.30%102.27M
53.84%275.61M
-32.93%128.78M
-32.93%128.78M
-20.97%150.59M
0.74%194.05M
-6.16%179.15M
Free cash flow
151.59%44.92M
-32.07%-30.69M
-40.43%-30.5M
-45.96%-25.58M
635.74%131.68M
-5.29%-87.05M
-11.29%-23.24M
-23.08%-21.72M
22.60%-17.52M
-14.20%-24.58M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 152.49%45.59M-31.31%-30.45M-40.49%-30.37M-45.46%-25.42M636.62%131.83M-7.13%-86.85M-12.33%-23.19M-25.21%-21.62M19.83%-17.48M-15.03%-24.57M
Net income from continuing operations 92.26%-6.89M-452.70%-57.93M-45.09%-38.35M8.61%-23.48M527.99%112.88M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M-16.98%-26.37M
Operating gains losses --145K--153K--------------------------------
Depreciation and amortization -18.70%1.77M-23.00%405K-18.15%442K-18.61%446K-15.28%477K-11.83%2.18M-15.71%526K-15.23%540K-10.31%548K-5.70%563K
Other non cash items 6.31%2.41M11.68%650K-4.20%547K8.90%612K8.91%599K0.22%2.27M-1.36%582K1.24%571K1.08%562K0.00%550K
Change In working capital 158.09%16.35M184.13%16.98M65.49%-1.12M-36,976.67%-11.12M347.56%11.61M-366.67%-28.14M-2,205.83%-20.18M-823.93%-3.24M-102.80%-30K20.18%-4.69M
-Change in receivables -8,436.00%-4.27M1,011.41%3.31M---------------50K--298K------------
-Change in prepaid assets 69.48%-545K112.64%220K494.94%5.64M-497.83%-3.85M-632.09%-2.56M-437.62%-1.79M-228.68%-1.74M284.44%948K-136.22%-644K83.29%-349K
-Change in payables and accrued expense 589.41%21.29M308.54%8.9M751.67%4.88M-22.70%2.77M347.06%4.74M196.26%3.09M289.64%2.18M-137.13%-749K180.80%3.58M-646.72%-1.92M
-Change in other working capital 99.56%-130K121.71%4.54M-31.22%-4.06M-238.78%-10.04M489.06%9.43M-777.11%-29.39M-1,838.09%-20.91M-66.88%-3.09M-179.61%-2.96M41.47%-2.42M
Cash from discontinued investing activities
Operating cash flow 152.49%45.59M-31.31%-30.45M-40.49%-30.37M-45.46%-25.42M636.62%131.83M-7.13%-86.85M-12.32%-23.19M-25.22%-21.62M19.83%-17.48M-15.03%-24.57M
Investing cash flow
Cash flow from continuing investing activities -73.82%-186.81M-7,555.56%-61.06M130.31%9.09M-68.19%-148.48M36.48%13.63M-201.44%-107.48M-94.46%819K-305.27%-30M-476.08%-88.28M-81.18%9.99M
Net PPE purchase and sale -230.05%-670K-452.38%-232K-28.16%-132K-234.78%-154K-1,166.67%-152K87.44%-203K81.66%-42K73.11%-103K94.52%-46K92.73%-12K
Net investment purchase and sale -73.52%-186.14M-7,164.92%-60.83M130.86%9.23M-68.11%-148.32M37.84%13.78M-199.73%-107.27M-94.26%861K-299.34%-29.9M-462.92%-88.23M-81.22%10M
Cash from discontinued investing activities
Investing cash flow -73.82%-186.81M-7,555.56%-61.06M130.31%9.09M-68.19%-148.48M36.48%13.63M-201.44%-107.48M-94.46%819K-305.27%-30M-476.08%-88.28M-81.18%9.99M
Financing cash flow
Cash flow from continuing financing activities -25.71%97.39M16,157.22%92.34M-61.76%3.12M-99.54%554K-19.98%1.37M147.31%131.09M-92.26%568K1,351.78%8.16M251,254.17%120.65M-96.19%1.72M
Net common stock issuance -31.87%87.78M8,778,300.00%87.78M--0--0--0147.38%128.84M-99.99%1K--7.66M--119.88M-97.10%1.3M
Proceeds from stock option exercised by employees 326.13%9.61M703.70%4.56M520.28%3.12M-27.68%554K228.71%1.37M143.41%2.25M11,240.00%567K-10.50%503K1,495.83%766K34.41%418K
Cash from discontinued financing activities
Financing cash flow -25.71%97.39M16,157.22%92.34M-61.76%3.12M-99.54%554K-19.98%1.37M147.31%131.09M-92.26%568K1,351.78%8.16M251,254.17%120.65M-96.19%1.72M
Net cash flow
Beginning cash position -32.93%128.78M-44.14%84.12M-47.30%102.27M53.84%275.61M-32.93%128.78M68.25%192.01M-20.97%150.59M0.74%194.05M-6.16%179.15M68.25%192.01M
Current changes in cash 30.67%-43.84M103.79%826K58.23%-18.15M-1,263.78%-173.35M1,241.69%146.83M-181.19%-63.23M-1,588.46%-21.81M-1,986.41%-43.46M765.49%14.9M-116.75%-12.86M
End cash Position -34.04%84.94M-34.04%84.94M-44.14%84.12M-47.30%102.27M53.84%275.61M-32.93%128.78M-32.93%128.78M-20.97%150.59M0.74%194.05M-6.16%179.15M
Free cash flow 151.59%44.92M-32.07%-30.69M-40.43%-30.5M-45.96%-25.58M635.74%131.68M-5.29%-87.05M-11.29%-23.24M-23.08%-21.72M22.60%-17.52M-14.20%-24.58M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -